SEC Form 4 · accession 0001104659-15-079897

Voyager Therapeutics, Inc. · VYGR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Other

Period of report

Nov 16, 2015

Accepted (ET)

Nov 18, 2015 · 2:26 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001640266

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common stock Par value per share $ 0.001	Nov 10, 2015	C	2,352,941	$0.00	A	2,352,941	I	Via wholly owned subsidiary Aventis Inc.
Common stock Par value per share $ 0.001	Nov 16, 2015	P	125,000	$14.00	A	2,477,941	I	Via wholly owned subsidiary Aventis Inc.

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Shares of Series B convertible preferred stock^F1	$0.00	Nov 10, 2015	C	10,000,000	D	—	—	Common stocks	2,352,941	0	I